Introduction. The objective of the study was to explore the role of a genetic variant of angiotensinogen (AGT), M235T, as an independent risk factor for acute myocardial infarction (AMI) and to investigate the possible association with the severity of coronary artery disease (CAD), estimated on the basis of the number of coronary stenoses and critical arterial occlusions.
Patients and methods. 123 AMI patients were compared to 144 healthy controls. AGT genotypes were determined by PCR.
Results. A significant association was found between AGT M235T polymorphism and AMI (p = .021). By logistic regression, the TT genotype appeared to confer 1.9-fold increased risk for AMI in both the univariate and the multivariate model. The frequencies of the TT genotype and T allele increased with the number of stenoses in coronary vessels. Moreover, the TT genotype and the T allele were more frequent in the subgroup of patients with stenoses in at least four coronary vessels than in other patients, including subjects with one- to three-vessel disease. Furthermore, the TT genotype and the T allele were significantly more frequent in patients with critical arterial occlusions (> 90%) than in subjects without critical stenoses.
Conclusions. The AGT M235T polymorphism associates with AMI risk and influences CAD severity.
Bader M., Wagner J., Lee MA, et al. The role of the renin-angiotensin system in cardiovascular disease . Hypertens Res1994; 17: 1-16.
2.
Zhu X., Yan D., Cooper RS, et al. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program . Genome Res2003; 13: 173-81.
3.
Jeunemaitre X., Soubrier F., Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell1992; 71: 169-80.
4.
Jeunemaitre X., Ledru F., Battaglia S., et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet1997; 99: 66-73.
5.
Rodriguez-Perez JC, Rodriguez-Esparragon F., Hernandez-Perera O., et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J Am Coll Cardiol2001; 37: 1536-42.
6.
Sethi AA, Tybjaerg-Hansen A., Gronholdt ML, et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med2001; 134: 941-54.
7.
Nair KG, Shalia KK, Ashavaid TF, et al. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal2003; 17: 141-6.
8.
Gardemann A. , Stricker J., Humme J., et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis1999; 145: 309-14.
9.
van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation1994; 89: 36-44.
10.
Pfeffer M.Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers. Am Heart J2000; 139: S23-S28.
Gensini GGA more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol1983; 51: 606.
13.
Smaoui M., Hammami S., Chaaba R., et al. Lipids and lipoprotein(a) concentrations in Tunisian type 2 diabetic patients; Relationship to glycemic control and coronary heart disease . J Diabetes Complications2004; 18: 258-63.
14.
Russ AP, Maerz W., Ruzicka V., et al. Rapid detection of the hypertension-associated Met235YThr allele of the human angiotensinogen gene. Hum Mol Genet1993; 2: 609-10.
15.
Staessen JA , Kuznetsova T., Wang JG, et al. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens1999; 17: 9-17.
16.
Kunz R., Kreutz R., Beige J., et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension1997; 30: 1331-7.
17.
Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A.Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol2003; 23: 1269-75.
18.
Mondry A., Loh M., Liu P., et al. Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol2005; 6: 1.
19.
Gould AB, Green D.Kinetics of the human renin and human substrate reaction. Cardiovasc Res1971; 5: 86-89.
20.
Ishigami T., Umemura S., Iwamoto T., et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation1995 ; 91: 951-954.
21.
Lanz JR, Pereira AC, Lemos PA, et al. Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta2005 ; 362: 176-81.
22.
Olivieri O. , Stranieri C., Girelli D., et al. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. J Hypertens2001; 19: 879-84.
23.
Pereira AC, Mota GF, Cunha RS, et al. Angiotensinogen 235T allele dosage is associated with blood pressure phenotypes. Hypertension2003; 41: 25-30.
24.
Goldenberg I., Moss AJ, Ryan D., et al. Polymorphism in the angiotensinogen gene, hypertension, and ethnic differences in the risk of recurrent coronary events. Hypertension. 2006; 48: 693-9.
25.
Reid IA, Morris BJ, Ganong W.j. The renin-angiotensin system. Annu Rev Physiol1978; 40: 377-410.
26.
Luft FCCardiac angiotensin is upregulated in the hearts of unstable angina patients . Circ Res2004; 94: 1530-2.
27.
Mancini GBRole of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease. Am J Med1998; 105: 40S-47S.
28.
Zhang H., Schmeisser A., Garlichs CD, et al. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res1999; 44: 215-22.
29.
Yao S.-K, Ober JC, Krishnaswami A., et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium injured arteries. Circulation1992; 86: 1302-9.
30.
Kugiyama K. , Yasue H., Okumura K., et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation1996; 94: 266-72.
31.
Yamagishi M. , Miyatake K., Tamai J., et al. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol1994; 23: 352-7.
